Enveric Biosciences Inc. (ENVB)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 37
-0.11
-7.4324%
$
913.43K Market Cap
- P/E Ratio
- Div Yield
171,490 Volume
-2.66 Eps
$ 1.48
Previous Close Want to track ENVB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enveric Biosciences Inc. (ENVB) Statistics
Valuation metrics
Market Cap 913.43K
Enterprise value -4M
Trailing P/E (ttm) -0.28
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.46
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.5
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 114.65K
Average volume (90 days) 3.69M
Price summary
52-Week low 1.35
52-Week high 17.64
Beta -
50-Day moving average 2.73
200-Day moving average 3.19
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 22 Apr 2008
Ex-Dividend Date 23 Apr 2008
Last split factor 1:12
Last split Date 28 Oct 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.49%
Return on equity -2.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.44
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.25
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 11.67%
Book value per share (mrq) 3.35
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
